Mar 26, 2026 7:00 am EDT Definium Therapeutics to Host Investor and Analyst Day in New York on April 22, 2026
Feb 26, 2026 4:01 pm EST Definium Therapeutics Reports Full-Year 2025 Financial Results and Business Updates
Feb 19, 2026 4:01 pm EST Definium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026
Jan 20, 2026 7:00 am EST Definium Therapeutics Introduces Rerouting Minds, an Educational Campaign Exploring the Potential of Pharmaceutical Lysergide (LSD) in Mental Health Care